BioSpace News Archive

Align Technology, Inc. announced the opening of its customer education and training center in Toronto, Canada to promote professional engagement and training about Invisalign clear aligners, iTero scanners and the Align Digital Platform™ for Align customers.

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Morgan Stanley 21st Annual Global Healthcare Conference.

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration has accepted the company’s Biologics License Application for crovalimab, an investigational, novel anti-C5 recycling monoclonal antibody, for the treatment of paroxysmal nocturnal hemoglobinuria.

Nucleome Therapeutics, a biotechnology company decoding the dark matter of the human genome for translational medicine, announces the appointment of Dr Russell Greig as Non-Executive Chair of the Board of Directors, with immediate effect.

Celltrion Group announced that the company will be attending the Morgan Stanley 21st Annual Global Healthcare Conference in New York City on Monday, September 11, 2023.

BVI announced the acquisition of Medical Mix, a company specializing in the supply of medical devices for ophthalmic surgery across Spain and Portugal.

Verona Pharma plc, announces an oral presentation on an additional analysis from its successful Phase 3 ENHANCE-1 study with ensifentrine for the treatment of chronic obstructive pulmonary disease will be presented at the European Respiratory Society International Congress 2023.

Proteros biostructures GmbH announced a new collaboration with Orion Corporation.

CANbridge Pharmaceuticals Inc., a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced its participation in two upcoming investor conferences.

Bühler, the Swiss technology group, and NRGene Technologies Ltd., an Israeli genomics company, announced a strategic collaboration in the field of black soldier fly genetics and processing.